Literature DB >> 8691452

Molecular modeling and site-directed mutagenesis studies of a phorbol ester-binding site in protein kinase C.

S Wang1, M G Kazanietz, P M Blumberg, V E Marquez, G W Milne.   

Abstract

The protein kinase C (PKC) binding site used by PKC activators such as phorbol esters and diacylglycerols (DAGs) has been characterized by means of molecular modeling and site-directed mutagenesis studies. Based upon a NMR-determined solution structure of the second cysteinerich domain of PKC alpha, molecular modeling was used to study the structures of the complexes formed between the PKC receptor and a number of PKC ligands, phorbol esters, and DAGs. Site-directed mutagenesis studies identified a number of residues important to the binding of phorbol esters to PKC. Analysis of the molecular modeling and mutagenesis results allows the development of a binding model for PKC ligands for which the precise binding nature is defined. The calculated hydrogen bond energies between the protein and various ligands in this binding model are consistent with their measured binding affinities. The binding site for phorbol esters and DAGs is located in a highly conserved, hydrophobic loop region formed by residues 6-12 and 20-27. For the binding elements in phorbol esters, the oxygen at C20 contributes most to the overall binding energy, and that at C3 plays a significant role. The oxygen atom at C12 is not directly involved in the interaction between phorbol esters and PKC. Our results also suggest that the oxygens at C9 and C13 are involved in PKC binding, while the oxygen at C4 is of minimal significance. These results are consistent with known structure-activity relationships in the phorbol ester family of compounds. Comparisons with the X-ray structure showed that although the X-ray data support the results for oxygens at C3, C12, and C20 of phorbol esters, they suggest different roles for oxygens at C4, C9, and C13. Several factors which may contribute to these discrepancies are discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8691452     DOI: 10.1021/jm950403n

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  5 in total

1.  Design and synthesis of triarylacrylonitrile analogues of tamoxifen with improved binding selectivity to protein kinase C.

Authors:  Colleen Carpenter; Roderick J Sorenson; Yafei Jin; Szymon Klossowski; Tomasz Cierpicki; Margaret Gnegy; Hollis D Showalter
Journal:  Bioorg Med Chem       Date:  2016-09-04       Impact factor: 3.641

2.  Conformation of the C1 phorbol-ester-binding domain participates in the activating conformational change of protein kinase C.

Authors:  C Ho; S J Slater; B A Stagliano; C D Stubbs
Journal:  Biochem J       Date:  1999-12-01       Impact factor: 3.857

3.  Selectivity analysis of 5-(arylthio)-2,4-diaminoquinazolines as inhibitors of Candida albicans dihydrofolate reductase by molecular dynamics simulations.

Authors:  V M Gokhale; V M Kulkarni
Journal:  J Comput Aided Mol Des       Date:  2000-07       Impact factor: 3.686

4.  Activation of nuclear factor κB (NF-κB) in prostate cancer is mediated by protein kinase C epsilon (PKCepsilon).

Authors:  Rachana Garg; Jorge Blando; Carlos J Perez; HongBin Wang; Fernando J Benavides; Marcelo G Kazanietz
Journal:  J Biol Chem       Date:  2012-09-06       Impact factor: 5.157

Review 5.  Structural insights into C1-ligand interactions: Filling the gaps by in silico methods.

Authors:  Sachin Katti; Tatyana I Igumenova
Journal:  Adv Biol Regul       Date:  2021-01-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.